Zenlabs Ethica Limited (ZENLABS.BO)

INR 40.85

(0.59%)

Market Cap (In INR)

265.93 Million

Revenue (In INR)

585.63 Million

Net Income (In INR)

4.21 Million

Avg. Volume

6219.00

Currency
INR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
19.15-41.2
PE
-
EPS
-
Beta Value
0.22453181
ISIN
INE546F01013
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
-
Employee Count
-
Website
http://www.zenlabsethica.com
Ipo Date
2000-04-10
Details
Zenlabs Ethica Ltd. engages in trading of pharmaceutical products. Its products include: Analgesics and Anti-Inflammatory; Skin Preparations; Neurological Disorders; Ear, Eye, and Nasal Drops; Anti-Diabetic; Anti-Depressant; Antiviral; Anti-Emetic; Steroids and Anabolic Steroids; Anti-Hypertensive Drugs; Anti Allergic, Anti Cold, and Cough Syrup; Nutraceuticals; Antacid, Enzymes, and Appetite Stimulant; Ayurvedic Preparation; GIT Disorders; and Other Pharmaceutical Drugs. The company was founded on July 20, 1993 and is headquartered in Chandigarh, India.